CStone Pharmaceuticals (2616) Ownership - Who Owns CStone Pharmaceuticals?

Q: What percentage of CStone Pharmaceuticals (HK:2616) stock is held by retail investors?

According to the latest TipRanks data, approximately 98.00% of CStone Pharmaceuticals (HK:2616) stock is held by retail investors.

Q: Who owns the most shares of CStone Pharmaceuticals (HK:2616)?

iShares owns the most shares of CStone Pharmaceuticals (HK:2616).

Q: What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

4 Followers

CStone Pharmaceuticals (2616) Ownership Overview

0.21%

Mutual Funds

1.79% ETFs

98.00% Public Companies and

Individual Investors

The ownership structure of CStone Pharmaceuticals (HK:2616) stock is a mix of institutional, retail, and individual investors. , and 98.00% is owned by Public Companies and Individual Investors.

The ownership structure of CStone Pharmaceuticals (HK:2616) stock is a mix of institutional, retail, and individual investors. Approximately 99.79% of the company’s stock is owned by Institutional Investors, 0.21% is owned by Insiders

Top Shareholders

# of Shares	Type	% Holding	Value
23,871,000	Institution	1.62%	28,478,103
2,303,300	Institution	0.16%	2,747,837
2,234,000	Institution	0.15%	2,665,162
624,500	Institution	0.04%	745,029
299,500	Institution	0.02%	357,304
228,500	Institution	0.02%	272,601
22,500	Institution	<0.01%	26,843

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
2,303,300	Institution	0.16%	2,747,837
624,500	Institution	0.04%	745,029
228,500	Institution	0.02%	272,601

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
iShares Core MSCI Emerging Markets ETF	14,356,500	Institution	0.97%	15,034,397
SPDR Portfolio Emerging Markets ETF	1,431,500	Institution	0.10%	1,262,249
SPDR S&P Emerging Markets Small Cap ETF	629,500	Institution	0.04%	555,072
iShares MSCI China Small-Cap ETF	525,000	Institution	0.04%	549,790
SPDR EM Sma Cap Accum.Shs Exchage Traded Fund USD	279,000	Institution	0.02%	246,013
iShares MSCI Emerging Markets Small Cap ETF	277,000	Institution	0.02%	290,080
iShr Core EmrgMktIMI	252,500	Institution	0.02%	308,398
iShares Core MSCI Emerging Markets IMI Index ETF Trust Units	252,500	Institution	0.02%	308,398
SPDR S&P China ETF	141,000	Institution	<0.01%	124,329
iShares MSCI AC Far East ex-Japan SmallCap UCITS ETF USD	73,000	Institution	<0.01%	64,369

FAQ

Who Owns CStone Pharmaceuticals (HK:2616)?

Currently, no data Available

What percentage of CStone Pharmaceuticals (HK:2616) stock is held by institutional investors?

Currently, no data Available

What percentage of CStone Pharmaceuticals (HK:2616) stock is held by retail investors?

According to the latest TipRanks data, approximately 98.00% of CStone Pharmaceuticals (HK:2616) stock is held by retail investors.

Who owns the most shares of CStone Pharmaceuticals (HK:2616)?

iShares owns the most shares of CStone Pharmaceuticals (HK:2616).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.